SPS
LYEL icon

Susquehanna Portfolio Strategies’s Lyell Immunopharma LYEL Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Hold
20,800
– – 0.01% 786
2025
Q4 		$640K Hold
20,800
– – 0.01% 729
2025
Q3 		$338K Sell
20,800
-900
-4% -$10.3K 0.01% 909
2025
Q2 		$192K Buy
+21,700
New +$198K ﹤0.01% 800

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
GP
GSK plc London $599M AUM
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna Portfolio Strategies's LYEL Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its Lyell Immunopharma (LYEL) position steady in Q1 2026 at 20,800 shares worth $417K. The position accounts for 0.01% of the portfolio, ranked #786.

Susquehanna Portfolio Strategies first reported a position in LYEL in Q2 2025 and has held it in 4 quarters since. The position peaked at $640K in Q4 2025. 74 funds tracked by Wall St. Rank hold LYEL as of Q1 2026.

  • Susquehanna Portfolio Strategies held 20,800 shares of Lyell Immunopharma worth $417K as of Q1 2026.
  • Susquehanna Portfolio Strategies left its Lyell Immunopharma share count unchanged in Q1 2026.
  • Lyell Immunopharma made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #786 holding.
  • Susquehanna Portfolio Strategies first reported a position in Lyell Immunopharma in Q2 2025 and has held it in 4 quarters since.
  • Susquehanna Portfolio Strategies's Lyell Immunopharma position peaked at $640K in Q4 2025.
  • 74 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.